Extension without change of a currently approved collection
No
Regular
11/01/2024
Requested
Previously Approved
36 Months From Approved
11/30/2024
1,942
668
764
239
0
0
This ICR collects information from
customers who wish to electronically submit a user fee refund
request for a duplicate payment, overpayment or for a withdrawn
application or submission. Respondents submit organization, contact
and payment information. Food and Drug Administration (FDA) has
developed Form 3913 to facilitate its review and processing of user
fee payment refunds. The information is used to determine the
reason for the refund, the refund amount and who to contact if
there are any questions regarding the refund request. A submission
of the User Fee Payment Refund Request form does not guarantee that
a refund will be issued. Additionally, this ICR collects
information from customers who wish to electronically submit a
request to transfer a user fee payment from one cover sheet or
invoice to another cover sheet or invoice. Respondents submit
payment and organization information. FDA has developed Form 3914
to facilitate its review and processing of user fee payment
transfer requests. The information is used to determine the reason
for the transfer, how the transfer should be performed and who to
contact if there are any questions regarding the transfer request.
A submission of the User Fee Payment Transfer Request form does not
guarantee that a transfer will be performed.
Our estimated burden for the
information collection reflects an overall increase of 525 hours
and a corresponding increase of 1,274 responses. These are
determined by the number of refund/transfer requests received from
industry. As the user fee programs mature, processes and procedures
utilized by industry also mature, leading to fewer requests for
transfers of fees or refunds.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.